Showing 41 - 50 of 847
Nonthawat Phakham, Published on 11/12/2025
» On every street in Bangkok, at every red light and alley, you will see motorcycles with colourful canvas boxes and banners attached to the drivers. The riders wear matching jackets, and those without boxes often have a passenger behind them. These are the application-based delivery workers known as Riders.
Published on 11/12/2025
» Novo Nordisk Pharma Thailand Ltd. (“Novo Nordisk”) and the Embassy of Denmark in Bangkok have donated 430,000 THB (around 86,000 DKK) to the Diabetes Association of Thailand to support relief efforts following the major floods in southern Thailand.
News, Post Reporters, Published on 26/11/2025
» Doctors have warned that more than 700,000 Thai smokers are living with diabetes, and nearly half of them are not aware of it.
AFP, Published on 19/11/2025
» PARIS - Researchers warned Wednesday that rising global consumption of ultra-processed foods (UPFs) poses a major threat to health, calling for countries to subject some products made by huge food companies to marketing restrictions and taxes.
Published on 17/11/2025
» Sanofi Thailand has received the "Corporate Social Impact Award 2025 - Gold level" for the 6th consecutive year from the American Chamber of Commerce in Thailand (AmCham Thailand), reinforcing its commitment to conducting business with social and community responsibility. The award recognises Sanofi's ongoing efforts to enhance Thai society's well-being and promote sustainability. Mr Charles Trolliet, Head of Commercial Thailand, Pharma Business, and Ms Wansiri Chuenjitkuntaworn, Head of Operations Thailand, Vaccines Business, proudly accepted the award at a ceremony held recently at Nikko Hotel.
Published on 14/11/2025
» Diabetes continues to be a significant public health priority in Thailand, affecting more than 6.5 million adults and accounting for over THB 47 billion in annual healthcare costs. According to the 2025 IDF Diabetes Atlas, the prevalence of diabetes among Thai adults aged 20–79 is 11.7% — the fourth highest in ASEAN and slightly above the global average of 11.1%. The Thai Ministry of Public Health also highlighted the elevated risk of cardiovascular complications and chronic kidney disease among people living with diabetes. As World Diabetes Day 2025 approaches, this moment offers a timely opportunity to rally collective action to accelerate progress in prevention, early detection and holistic diabetes care.
Published on 12/11/2025
» Thammasat University Hospital, the Faculty of Medicine, Thammasat University, and Novo Nordisk Pharma (Thailand) Ltd. have signed a Memorandum of Understanding (MOU) to expand clinical trials at the hospital, building on their previous collaboration to tackle Diabetes and Obesity. This new agreement aims to drive positive change in the management and treatment of cardio-metabolic diseases in Thailand.
Published on 12/11/2025
» A major step forward in Bangkok’s public health journey was marked by the signing of a Memorandum of Understanding (MOU) to establish “Bangkok, City for Better Health” — a collaborative initiative between the Bangkok Metropolitan Administration (BMA), the Royal Danish Embassy Bangkok, and Novo Nordisk Pharma Thailand Ltd. The ceremony, held at the Embassy of Denmark, also unveiled the “Childhood Obesity Curriculum”, a tangible outcome of the project’s early success.
News, Apinya Wipatayotin, Published on 09/11/2025
» Thailand is facing worsening public health trends that could fuel a surge in non-communicable diseases (NCDs) in coming years, says the latest National Health Examination Survey (NHES).
News, Poramet Tangsathaporn, Published on 08/11/2025
» The Bangkok Metropolitan Administration (BMA), the Danish Embassy, and Novo Nordisk Pharma Thailand have signed a Memorandum of Understanding (MoU) to promote healthier urban lifestyles and combat obesity under the "Bangkok, City for Better Health" initiative.